Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction of Epclusa 400mg/100mg Tablet:
Epclusa 400mg/100mg Tablet is a blend of two antiviral medications used in the therapy of ongoing hepatitis C infection (HCV) disease. It fights against the infections to resolve the disease.
Epclusa 400mg/100mg Tablet should be taken in the recommended portion and term. It can be taken regardless of food, but take it at the same time daily. Consuming more than the suggested dose is not advised. It is crucial to inform your primary care physician if you have any ailments like liver or kidney infection. It is risky to consume alcohol alongside this medication, so it is recommended to limit or avoid alcohol. The course of the medication should be completed for improved results.
Uses of Epclusa 400mg/100mg Tablet:
Therapy of Chronic hepatitis C infection (HCV) disease
Benefits of Epclusa 400mg/100mg Tablet:
In Treatment of Chronic hepatitis C infection (HCV) disease
Hepatitis C is a liver disease caused by the hepatitis C virus (HCV). When the disease progresses to a chronic stage, it is called chronic hepatitis C infection disease. Epclusa 400mg/100mg Tablet reduces the quantity of hepatitis C virus by preventing its spread in your body. This helps control the disease and assists in quicker recovery. You should take this medication as prescribed, following the dosage recommended by your PCP.
Mechanism of action of Epclusa 400mg/100mg Tablet:
Epclusa 400mg/100mg Tablet is a blend of two antiviral medications: Sofosbuvir and Velpatasvir. They work by reducing the amount of hepatitis C virus in the body and eliminating the virus from the blood over a period of time.